MacroGenics | MGNX - Stock


MacroGenics reported $9.5M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
AbbVie USD 5.05B 98M Mar/2026
Amgen USD 6.19B 39M Mar/2026
AstraZeneca USD 6.57B 13M Mar/2026
Biogen USD 1.95B 219.1M Mar/2026
Bristol-Myers Squibb USD 2.76B 66M Mar/2026
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Eli Lilly USD 14.53B 785M Mar/2026
Genmab DKK 13M 1000K Jun/2025
Geron USD 133.29M 16.65M Mar/2026
Gilead Sciences USD 1.91B 140M Mar/2026
J&J USD 14.58B 392M Mar/2026
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 9.5M 1.59M Mar/2026
Merck USD 6.48B 179M Mar/2026
Pfizer USD 10.67B 13M Mar/2026
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.1B 97.2M Mar/2026
Roche Holding CHF 7.6B 9M Jun/2025